drugset / Trial / NCT01314989

Cyproheptadine as an Appetite Stimulant

NCT01314989

Phase 4 Unknown 20 enrolled St. Justine's Hospital
RandomizedCrossoverTriple-blindTreatment

Summary

Cyproheptadine is currently clinically used as an appetite stimulant for children with failure to thrive without underlying organic disease. Otherwise, no randomised control trial demonstrates the efficacy of Cyproheptadine on those patients. This is precisely what the investigators intend to demonstrate on this randomised placebo control cross-over trial. Our hypothesis is that Cyproheptadine is more efficient than placebo to improve weight gain and feeding behaviour on 2 to 4 years old children with failure to thrive.

Timeline

Start
2010-12
Primary completion
2011-03
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyproheptadine Small molecule 0.25 mg/kg Oral

Indications

No indication recorded.